TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
The Brazil Enilconazole market size was valued at US$ 18 million in 2024 and is projected to reach US$ 23 million by 2030, at a CAGR of 4.2% during the forecast period 2024-2030.
Enilconazole, also known as imazalil, is a systemic fungicide used primarily for post-harvest treatment of fruits and vegetables, as well as for seed treatment and some foliar applications.
Brazil's enilconazole market is experiencing moderate growth, driven by its importance in post-harvest disease control for export-oriented fruit production. In 2023, citrus fruits accounted for 45% of enilconazole use in Brazil, followed by bananas at 25%. The market saw an 8% increase in demand for enilconazole-based post-harvest treatments in 2023, particularly for managing green mold and stem-end rot in citrus. Use in seed treatment applications is growing at 5% annually. Key players are investing in developing improved formulations, with a 10% year-over-year increase in product launches featuring enhanced residue profiles and application technologies. The industry is also witnessing a trend towards integrated post-harvest management, with a 12% rise in protocols combining enilconazole with non-chemical treatments for improved disease control and reduced residues. Brazil's efforts to expand its fruit export markets continue to drive enilconazole demand, with a 7% increase in applications for meeting stringent international quality standards. However, growing consumer pressure for residue-free produce is prompting research into alternative post-harvest treatments.
This report contains market size and forecasts of Enilconazole in Brazil, including the following market information:
• Brazil Enilconazole Market Revenue, 2019-2024, 2024-2030, ($ millions)
• Brazil Enilconazole Market Sales, 2019-2024, 2024-2030,
• Brazil Top five Enilconazole companies in 2023 (%)
Report Includes
This report presents an overview of Brazil market for Enilconazole , sales, revenue and price. Analyses of the Brazil market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report focuses on the Enilconazole sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the Brazil Enilconazole market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues.
This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Sales Channels, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Humidifier sales, projected growth trends, production technology, sales channels and end-user industry.
• EC
• SG
• Fruits
• Crops
• Other
Key Companies covered in this report:
• Bayer S.A.
• Zoetis Brasil
• Elanco Brasil
• Merck Animal Health Brazil
• Virbac Brasil
• Boehringer Ingelheim Brasil
• Ceva Sa
1.1 Enilconazole Product Introduction
1.2.1 Braziln Enilconazole Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 EC
1.2.3 SG
1.3.1 Brazil Enilconazole Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Fruits
1.3.3 Crops
1.3.4 Other
1.4 Brazil Enilconazole Sales Estimates and Forecasts 2019-2030
1.5 Brazil Enilconazole Hydrocephalus Shunts Revenue Estimates and Forecasts 2019-2030
1.6 Study Objectives
1.7 Years Considered
2.1 Brazil Enilconazole Sales by Manufacturers
2.1.1 Brazil Enilconazole Sales by Manufacturers (2019-2024)
2.1.2 Brazil Enilconazole Sales Market Share by Manufacturers (2019-2024)
2.1.3 Top Largest Manufacturers of Enilconazole in 2023 in Brazil
2.2 Brazil Enilconazole Revenue by Manufacturers
2.2.1 Brazil Enilconazole Revenue by Manufacturers (2019-2024)
2.2.2 Brazil Enilconazole Revenue Market Share by Manufacturers (2019-2024)
2.2.3 Brazil Top Companies by Enilconazole Revenue in 2023
2.3 Brazil Enilconazole Sales Price by Manufacturers (2019-2024)
2.4 Analysis of Competitive Landscape
2.4.1 Manufacturers Market Concentration Ratio (CR3 and HHI)
2.4.2 Brazil Enilconazole by Company Type (Tier 1, Tier 2, and Tier 3)
2.4.3 Brazil Enilconazole Manufacturers Geographical Distribution
2.5 Mergers & Acquisitions, Expansion Plans
3.1 Enilconazole Market Size by Region: 2019-2030
3.1.1 Brazil Enilconazole Sales by Region: 2019-2024
3.1.2 Brazil Enilconazole Sales Forecast by Region (2025-2030)
3.1.3 Brazil Enilconazole Revenue by Region: 2019-2024
3.1.4 Brazil Enilconazole Revenue Forecast by Region (2025-2030)
4.1 Brazil Enilconazole Sales by Type
4.1.1 Brazil Enilconazole Historical Sales by Type (2019-2024)
4.1.2 Brazil Enilconazole Forecasted Sales by Type (2025-2030)
4.1.3 Brazil Enilconazole Sales Market Share by Type (2019-2030)
4.2 Brazil Enilconazole Revenue by Type
4.2.1 Brazil Enilconazole Historical Revenue by Type (2019-2024)
4.2.2 Brazil Enilconazole Forecasted Revenue by Type (2025-2030)
4.2.3 Brazil Enilconazole Revenue Market Share by Type (2019-2030)
4.3 Brazil Enilconazole Price by Type
4.3.1 Brazil Enilconazole Price by Type (2019-2024)
4.3.2 Brazil Enilconazole Price Forecast by Type (2025-2030)
5.1 Brazil Enilconazole Sales by Application
5.1.1 Brazil Enilconazole Historical Sales by Application (2019-2024)
5.1.2 Brazil Enilconazole Forecasted Sales by Application (2025-2030)
5.1.3 Brazil Enilconazole Sales Market Share by Application (2019-2030)
5.2 Brazil Enilconazole Revenue by Application
5.2.1 Brazil Enilconazole Historical Revenue by Application (2019-2024)
5.2.2 Brazil Enilconazole Forecasted Revenue by Application (2025-2030)
5.2.3 Brazil Enilconazole Revenue Market Share by Application (2019-2030)
5.3 Brazil Enilconazole Price by Application
5.3.1 Brazil Enilconazole Price by Application (2019-2024)
5.3.2 Brazil Enilconazole Price Forecast by Application (2025-2030)
6.1 Bayer S.A.
6.1.1 Bayer S.A. Corporation Information
6.1.2 Bayer S.A. Overview
6.1.3 Bayer S.A. in Brazil: Enilconazole Sales, Price, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer S.A. Enilconazole Product Introduction
6.1.5 Bayer S.A. Recent Developments
6.2 Zoetis Brasil
6.2.1 Zoetis Brasil Corporation Information
6.2.2 Zoetis Brasil Overview
6.2.3 Zoetis Brasil in Brazil: Enilconazole Sales, Price, Revenue and Gross Margin (2019-2024)
6.2.4 Zoetis Brasil Enilconazole Product Introduction
6.2.5 Zoetis Brasil Recent Developments
6.3 Elanco Brasil
6.3.1 Elanco Brasil Corporation Information
6.3.2 Elanco Brasil Overview
6.3.3 Elanco Brasil in Brazil: Enilconazole Sales, Price, Revenue and Gross Margin (2019-2024)
6.3.4 Elanco Brasil Enilconazole Product Introduction
6.3.5 Elanco Brasil Recent Developments
6.4 Merck Animal Health Brazil
6.4.1 Merck Animal Health Brazil Corporation Information
6.4.2 Merck Animal Health Brazil Overview
6.4.3 Merck Animal Health Brazil in Brazil: Enilconazole Sales, Price, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Animal Health Brazil Enilconazole Product Introduction
6.4.5 Merck Animal Health Brazil Recent Developments
6.5 Virbac Brasil
6.5.1 Virbac Brasil Corporation Information
6.5.2 Virbac Brasil Overview
6.5.3 Virbac Brasil in Brazil: Enilconazole Sales, Price, Revenue and Gross Margin (2019-2024)
6.5.4 Virbac Brasil Enilconazole Product Introduction
6.5.5 Virbac Brasil Recent Developments
6.6 Boehringer Ingelheim Brasil
6.6.1 Boehringer Ingelheim Brasil Corporation Information
6.6.2 Boehringer Ingelheim Brasil Overview
6.6.3 Boehringer Ingelheim Brasil in Brazil: Enilconazole Sales, Price, Revenue and Gross Margin (2019-2024)
6.6.4 Boehringer Ingelheim Brasil Enilconazole Product Introduction
6.6.5 Boehringer Ingelheim Brasil Recent Developments
6.7 Ceva Sa
Frequently Asked Questions ?
